TY - JOUR
KW - Analgesics, Opioid/administration & dosage/adverse effects
KW - Arrhythmias, Cardiac/chemically induced
KW - Diarrhea/drug therapy
KW - Drug Overdose/prevention & control
KW - Humans
KW - Loperamide/administration & dosage/adverse effects/therapeutic use
KW - Opioid-Related Disorders/prevention & control/psychology
KW - Patient Selection
KW - Practice Guidelines as Topic
KW - Prescription Drug Misuse/prevention & control/statistics & numerical data
AU - P. E. Wu
AU - D. N. Juurlink
A1 - 
AD - Department of Medicine, University Health Network, Toronto, Ontario, Canada; Division of Clinical Pharmacology and Toxicology and Department of Medicine, University of Toronto, Toronto, Ontario, Canada. Electronic address: peter.wu@uhn.ca.; Division of Clinical Pharmacology and Toxicology and Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Institute for Clinical and Evaluative Sciences and Sunnybrook Research Institute, Toronto, Ontario, Canada.
BT - Annals of Emergency Medicine
C5 - Opioids & Substance Use
CP - 2
CY - United States
IS - 2
JF - Annals of Emergency Medicine
M1 - Journal Article
PB - American College of Emergency Physicians. Published by Elsevier Inc
PP - United States
PY - 2017
SN - 1097-6760; 0196-0644
SP - 245
EP - 252
EP - 
T1 - Clinical Review: Loperamide Toxicity
T2 - Annals of Emergency Medicine
TI - Clinical Review: Loperamide Toxicity
U1 - Opioids & Substance Use
U2 - 28506439
VL - 70
VO - 1097-6760; 0196-0644
Y1 - 2017
Y2 - Aug
ER -